10 results

669 Rewiring the scar: translational advances in cardiac fibrosis
Tu Nguyen Tran, Phuoc Hoang Le, Seonbu Yang, Trang Luong, Jaetaek Kim
KMSID: 1516092984   Korean J Physiol Pharmacol. 2025;29(6):669-682.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.25.160
      
683 Organoid-based modeling and regenerative strategies for salivary gland dysfunction
Hee-Jeong Park, Jaejin Cho, Su-Jeong Oh, Hyung-Sik Kim
KMSID: 1516092985   Korean J Physiol Pharmacol. 2025;29(6):683-698.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.25.149
      
699 Endothelial to mesenchymal transition: a central mechanism in diabetes-induced vascular pathology
Giang-Huong Vu, Byeong Hwa Jeon, Cuk-Seong Kim
KMSID: 1516092986   Korean J Physiol Pharmacol. 2025;29(6):699-711.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.25.236
      
713 Chick early amniotic fluid attenuates lipopolysaccharide-induced acute lung injury
Chengxin Yin, Shan Lin, Jianzhou Li, Xiejiu Chen, Borui Li, Hui Yang, Baiping Cui
KMSID: 1516092987   Korean J Physiol Pharmacol. 2025;29(6):713-725.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.24.379
      
727 Poricoic Acid A attenuated TGF-β1-induced epithelial-mesenchymal transition in renal tubular epithelial cells through SPRY2/ERK signaling pathway
Ming Xiang, Haiying Chen, Xiangdong Lin
KMSID: 1516092989   Korean J Physiol Pharmacol. 2025;29(6):727-739.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.24.384
      
741 OAC1 improves mitofusin 2 expression to alleviate neuronal injury following experimental ischemic stroke
Yuanyuan Wang, Kechun Chen, Bingtian Xu, Haitao Wang, Honghao Wang, Tianming Lü
KMSID: 1516092988   Korean J Physiol Pharmacol. 2025;29(6):741-753.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.24.428
      
755 Vericiguat reduces pyroptosis in rats with coronary microembolization by inhibiting the AMPK/Nrf2/NLRP3 signaling pathway
Eksavang Khounphinith, You Zhou, Zeqiang Yi, Tao Li, Lang Li
KMSID: 1516092990   Korean J Physiol Pharmacol. 2025;29(6):755-767.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.25.008
      
769 Fimepinostat is a dual inhibitor of tumor and angiogenesis in glioblastoma and synergizes with temozolomide through suppressing MYC
Weifeng Wan, Xin Zhang, Hongcai Du, Changren Huang, Ligang Chen, Xiaobo Yang, Kunyang Bao
KMSID: 1516092991   Korean J Physiol Pharmacol. 2025;29(6):769-778.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.25.056
      
779 Retraction to: Edaravone alleviates lung damage in mice with hypoxic pulmonary hypertension by increasing nitric oxide synthase 3 expression
Wan Zheng, Tianfa Li, Junping Wei, Yani Yan, Shanshan Yang
KMSID: 1516092992   Korean J Physiol Pharmacol. 2025;29(6):779-779.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.22.161rt
781 Retraction to: Rehmannioside D mitigates disease progression in rats with experimental-induced diminished ovarian reserve via Forkhead Box O1/KLOTHO axis
Yan Liang, Huimin Wang, Jin Chen, Lingyan Chen, Xiaoyong Chen
KMSID: 1516092993   Korean J Physiol Pharmacol. 2025;29(6):781-781.   Published online 2025 November 1    DOI: http://dx.doi.org/10.4196/kjpp.22.196rt
Articles from The Korean Journal of Physiology & Pharmacology are provided here courtesy of The Korean Physiological Society; The Korean Society of Pharmacology